Endothelial destabilization by angiopoietin-2 via integrin β1 activation

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hakanpaa, Laura ^a   Sipila, Tuomas ^a   Leppanen, Veli Matti ^a   Gautam, Prson ^a   Nurmi, Harri ^a   Jacquemet, Guillaume ^b   Eklund, Lauri ^c   Ivaska, Johanna ^b   Alitalo, Kari ^a   Saharinen, Pipsa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BETA1 INTEGRIN; CADHERIN; PHOSPHATIDYLINOSITOL 3 KINASE; RHO KINASE; TIE RECEPTOR; ANGIOPOIETIN RECEPTOR;

CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; GENE EXPRESSION; HOMEOSTASIS; METABOLISM; MUTATION; PROTEIN; RODENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL ADHESION; CELL JUNCTION; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOLAYER CULTURE; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS FIBER; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TRANSGENIC MOUSE; TUMOR CELL; VASCULAR ENDOTHELIUM; ANIMAL; CELL LINE; ENDOTHELIUM CELL; FEMALE; GENETICS; MALE; METABOLISM; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION;

MUS MUSCULUS;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; ANTIGENS, CD29; CELL LINE; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, TIE-2;

EID: 84952027392     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6962     Document Type: Article

References (55)

1. Augustin, H. G., Koh, G. Y., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. 10, 165-177 (2009).
2. Eklund, L. & Saharinen, P. Angiopoietin signaling in the vasculature. Exp. Cell Res. 319, 1271-1280 (2013).
3. Suri, C. et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180 (1996).
4. Jeansson, M. et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 121, 2278-2289 (2011).
5. Hayashi, M. et al. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat. Commun. 4, 1672 (2013).
6. Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60 (1997).
7. Daly, C. et al. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition. Cancer Res. 73, 108-118 (2013).
8. Holash, J. et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998 (1999).
9. Parikh, S. M. et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 3, e46 (2006).
10. David, S. et al. Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L851-L862 (2011).
11. Kurniati, N. F. et al. The flow dependency of Tie2 expression in endotoxemia. Intensive Care Med. 39, 1262-1271 (2013).
12. Fiedler, U. et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 12, 235-239 (2006).
13. Saharinen, P. et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol. 10, 527-537 (2008).
14. Benest, A. V. et al. Angiopoietin-2 is critical for cytokine-induced vascular leakage. PLoS ONE 8, e70459 (2013).
15. Ziegler, T. et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J. Clin. Invest. 123, 3436-3445 (2013).
16. Syrjala, S. O. et al. Angiopoietin-2 inhibition prevents transplant ischemiareperfusion injury and chronic rejection in rat cardiac allografts. Am. J. Transplant. 14, 1096-1108 (2014).
17. Oliner, J. et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 6, 507-516 (2004).
18. Mazzieri, R. et al. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19, 512-526 (2011).
19. Holopainen, T. et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl Cancer Inst. 104, 461-475 (2012).
20. Zheng, W et al. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes Dev. 28, 1592-1603 (2014).
21. Dumont, D. J. et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8, 1897-1909 (1994).
22. Carlson, T. R., Feng, Y., Maisonpierre, P. C., Mrksich, M. & Morla, A. O. Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276, 26516-26525 (2001).
23. Chen, X., Fu, W., Tung, C. E. & Ward, N. L. Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrin-dependent manner. Neurosci. Res. 64, 348-354 (2009).
24. Scholz, A. et al. Angiopoietin-2 promotes myeloid cell infiltration in a beta(2)-integrin-dependent manner. Blood 118, 5050-5059 (2011).
25. Lee, J. et al. Angiopoietin-1 Guides Directional Angiogenesis Through Integrin avb5 Signaling for Recovery of Ischemic Retinopathy. Sci Transl Med 5, 203ra127 (2013).
26. del Toro, R. et al. Identification and functional analysis of endothelial tip cellenriched genes. Blood 116, 4025-4033 (2010).
27. Felcht, M. et al. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J. Clin. Invest. 122, 1991-2005 (2012).
28. Fiedler, U. et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103, 4150-4156 (2004).
29. Giannotta, M., Trani, M. & Dejana, E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev. Cell 26, 441-454 (2013).
30. Shen, Q., Wu, M. H. & Yuan, S. Y. Endothelial contractile cytoskeleton and microvascular permeability. Cell Health Cytoskelet. 2009, 43-50 (2009).
31. Wick, N. et al. Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol. Genomics 28, 179-192 (2007).
32. Reymond, N., d'Agua, B. B. & Ridley, A. J. Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 13, 858-870 (2013).
33. Cascone, I., Napione, L., Maniero, F., Serini, G. & Bussolino, F. Stable interaction between {alpha}5{beta}1 integrin and tie2 tyrosine kinase receptor regulates endothelial cell response to ang-1. J. Cell Biol. 170, 993-1004 (2005).
34. Thomas, M. et al. Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation. J. Biol. Chem. 285, 23842-23849 (2010).
35. Faurobert, E. et al. CCM1-ICAP-1 complex controls beta1 integrin-dependent endothelial contractility and fibronectin remodeling. J. Cell Biol. 202, 545-561 (2013).
36. Pankov, R. et al. Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis. J. Cell Biol. 148, 1075-1090 (2000).
37. Su, G. et al. Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin alphavbeta5. Crit. Care Med. 41, 546-553 (2013).
38. Alghisi, G. C., Ponsonnet, L. & Ruegg, C. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS ONE 4, e4449 (2009).
39. Su, G. et al. Absence of integrin alphavbeta3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am. J. Resp. Crit. Care Med. 185, 58-66 (2012).
40. Reardon, D. A. & Cheresh, D. Cilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies. Genes Cancer 2, 1159-1165 (2011).
41. Fukuhara, S. et al. Differential function of Tie2 at cell-cell contacts and cellsubstratum contacts regulated by angiopoietin-1. Nat. Cell Biol. 10, 513-526 (2008).
42. Bouaouina, M., Harburger, D. S. & Calderwood, D. A. Talin and signaling through integrins. Methods Mol. Biol. 757, 325-347 (2012).
43. Harburger, D. S., Bouaouina, M. & Calderwood, D. A. Kindlin-1 and-2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrinspecific activation effects. J. Biol. Chem. 284, 11485-11497 (2009).
44. Calderwood, D. A. et al. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem. 274, 28071-28074 (1999).
45. Chiu, J. J. & Chien, S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 91, 327-387 (2011).
46. Reiss, Y. et al. Angiopoietin-2 impairs revascularization after limb ischemia. Circ. Res. 101, 88-96 (2007).
47. Tabruyn, S. P. et al. Angiopoietin-2-driven vascular remodeling in airway inflammation. Am. J. Pathol. 177, 3233-3243 (2010).
48. Pietila, R. et al. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses. J. Cell Sci. 125, 2212-2223 (2012).
49. McCarter, S. D. et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am. J. Resp. Crit. Care Med. 175, 1014-1026 (2007).
50. Rasmussen, A. L. et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science 346, 987-991 (2014).
51. Ory, D. S., Neugeboren, B. A. & Mulligan, R. C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl Acad. Sci. USA 93, 11400-11406 (1996).
52. Ylanne, J. & Virtanen, I. The Mr 140, 000 fibronectin receptor complex in normal and virus-transformed human fibroblasts and in fibrosarcoma cells: identical localization and function. Int. J. Cancer 43, 1126-1136 (1989).
53. Brown, P. J. & Juliano, R. L. Selective inhibition of fibronectin-mediated cell adhesion by monoclonal antibodies to a cell-surface glycoprotein. Science 228, 1448-1451 (1985).
54. Saharinen, P. et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J. Cell Biol. 169, 239-243 (2005).
55. Zacharias, D. A., Violin, J. D., Newton, A. C. & Tsien, R. Y. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913-916 (2002).